STOCK TITAN

Pacira BioSciences to Present at Two Healthcare Conferences in May

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

TAMPA, Fla., May 10, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences (NASDAQ: PCRX) will participate in two upcoming healthcare conferences:

  • RBC Capital Markets Global Healthcare Conference on May 17 at 8:00 AM ET.
  • H.C. Wainwright Global Virtual Investment Conference on May 24 at 7:00 AM ET.

Live audio can be accessed on the company’s website, with replays available for two weeks post-events. Pacira's commitment lies in providing non-opioid pain management solutions.

Positive
  • None.
Negative
  • None.

TAMPA, Fla., May 10, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the following two healthcare conferences:

  • 2022 RBC Capital Markets Global Healthcare Conference in New York, on Tuesday, May 17th at 8:00AM ET.
  • H.C. Wainwright Global Virtual Investment Conference on Tuesday, May 24th at 7:00AM ET.

Live audio of the events can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcasts will also be available for two weeks following the events.

About Pacira         

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.


FAQ

What events is Pacira BioSciences participating in May 2022?

Pacira is participating in the RBC Capital Markets Global Healthcare Conference on May 17 and the H.C. Wainwright Global Virtual Investment Conference on May 24.

What time is Pacira's fireside chat at the RBC Capital Markets Conference?

The fireside chat at the RBC Capital Markets Conference is scheduled for May 17 at 8:00 AM ET.

Where can I listen to Pacira BioSciences' conference webcasts?

The live audio of Pacira's events can be accessed through the 'Events' page on their investor website.

What is Pacira's mission regarding opioids?

Pacira aims to provide non-opioid options for pain management to reduce the reliance on opioids.

What are the main products offered by Pacira BioSciences?

Pacira offers non-opioid treatments including EXPAREL, ZILRETTA, and iovera for pain management.

Pacira BioSciences, Inc.

NASDAQ:PCRX

PCRX Rankings

PCRX Latest News

PCRX Stock Data

1.14B
45.13M
2.15%
114.51%
10.29%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TAMPA